Rodan S B, Wesolowski G, Ianacone J, Thiede M A, Rodan G A
Department of Bone Biology and Osteoporosis Research, Merck Sharp & Dohme Research Laboratories, West Point, Pennsylvania 19486.
J Endocrinol. 1989 Jul;122(1):219-27. doi: 10.1677/joe.0.1220219.
A clonal cell line (Saos-2/B-10) derived from human osteosarcoma Saos-2 cells had the same osteoblastic characteristics as the mother line, but lacked sensitivity to parathyroid hormone (PTH) at early passages. At later passages (greater than 70) the cells became very sensitive to PTH (0.1 nmol/l). The absence of PTH-stimulatable adenylate cyclase correlated with the secretion of an adenylate cyclase-stimulatory activity which had the properties of the recently characterized PTH-like peptide (PTH-LP). This activity was inhibited by the PTH antagonist [8norleucyl,18norleucyl,34tyrosinyl]bovine PTH-(3-34)amide and could be neutralized by an antiserum raised against the synthetic PTH-LP-(1-34). Hybridization with a human PTH-LP cDNA showed that these cells produce two PTH-LP mRNAs of approximately 1.5 and 1.8 kb. The production of PTH-LP was stimulated by 12-O-tetradecanoyl-phorbol-13-acetate (TPA; 150 nmol/l) and epidermal growth factor (EGF; 10 ng/ml). The increased accumulation of PTH-LP in conditioned media in response to TPA was seen after 1 h and levelled off at 6 h. In contrast, EGF stimulation was lower at 3 and 6 h but continued for 24 h. Both agents increased PTH-LP mRNA levels in Saos-2/B-10 cells. A TPA analogue which does not stimulate protein kinase C had no effect on PTH-LP production. Cycloheximide blocked the stimulatory effect of both TPA and EGF and the TPA effect was blocked by actinomycin D, suggesting transcriptional control. The regulation of PTH-LP by these agents may offer clues regarding the association of this protein with malignancy.
一株源自人骨肉瘤Saos-2细胞的克隆细胞系(Saos-2/B-10)具有与母系相同的成骨细胞特征,但在传代早期对甲状旁腺激素(PTH)不敏感。在传代后期(大于70代),细胞对PTH(0.1 nmol/l)变得非常敏感。缺乏PTH刺激的腺苷酸环化酶与一种腺苷酸环化酶刺激活性的分泌相关,该活性具有最近鉴定的甲状旁腺激素样肽(PTH-LP)的特性。这种活性被PTH拮抗剂[8-去甲亮氨酰,18-去甲亮氨酰,34-酪氨酰]牛PTH-(3-34)酰胺抑制,并可被针对合成PTH-LP-(1-34)产生的抗血清中和。与人PTH-LP cDNA杂交显示,这些细胞产生两种大小约为1.5和1.8 kb的PTH-LP mRNA。PTH-LP的产生受到12-O-十四烷酰佛波醇-13-乙酸酯(TPA;150 nmol/l)和表皮生长因子(EGF;10 ng/ml)的刺激。TPA作用后1小时,条件培养基中PTH-LP的积累增加,并在6小时达到平稳。相比之下,EGF刺激在3小时和6小时较低,但持续24小时。两种试剂均增加了Saos-2/B-10细胞中PTH-LP mRNA水平。一种不刺激蛋白激酶C的TPA类似物对PTH-LP的产生没有影响。放线菌酮阻断了TPA和EGF的刺激作用,而TPA的作用被放线菌素D阻断,提示存在转录调控。这些试剂对PTH-LP的调节可能为该蛋白与恶性肿瘤的关联提供线索。